US Stock MarketDetailed Quotes
IDGGW INTERPACE BIOSCIENCES INC C/WTS 21/06/2022 (TO PUR COM)
- 0.000000
- 0.0000000.00%
15min DelayClose Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)4.17MShares0.00040052wk High0.00P/B0Float Cap0.00030052wk Low--Dividend TTM4.17MShs Float0.295000Historical High--Div YieldTTM0.00%Amplitude0.000300Historical Low--Avg Price1Lot Size
INTERPACE BIOSCIENCES INC C/WTS 21/06/2022 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 74.95%-1.25M | 37.63%-8.72M | 23.11%-1.22M | 88.19%-676K | -505.12%-1.82M | 29.71%-5.01M | 26.26%-13.98M | 75.25%-1.58M | -19.93%-5.72M | 109.31%449K |
| Net income from continuing operations | 46.59%-2.25M | 43.51%-14.94M | 54.21%-3.73M | 42.88%-3.56M | 38.24%-3.45M | 35.22%-4.21M | 1.08%-26.45M | 23.63%-8.14M | 16.29%-6.23M | -5.20%-5.58M |
| Operating gains losses | -253.66%-63K | 203.28%63K | -7,500.00%-74K | -453.85%-72K | 830.43%168K | 257.69%41K | 78.14%-61K | 100.41%1K | -230.00%-13K | 45.24%-23K |
| Depreciation and amortization | -49.02%781K | -2.31%5.37M | -26.80%1.02M | 0.93%1.41M | 1.58%1.41M | 16.15%1.53M | 21.60%5.5M | 2.87%1.4M | 11.79%1.39M | 44.69%1.39M |
| Deferred tax | ---- | 2.70%38K | ---- | ---- | ---- | ---- | 105.56%37K | ---- | ---- | ---- |
| Other non cash items | -89.04%24K | 986.67%652K | 125.14%89K | 102.17%279K | -61.08%65K | 100.92%219K | -98.46%60K | -109.99%-354K | 24.32%138K | 83.52%167K |
| Change In working capital | 97.30%-74K | -121.64%-1.13M | -67.48%1.38M | 291.79%794K | -113.87%-568K | -1.45%-2.74M | 317.16%5.23M | 701.84%4.24M | -139.35%-414K | 376.57%4.1M |
| -Change in receivables | -441.64%-1.08M | 24.52%2.15M | 260.00%360K | 177.37%947K | -79.53%524K | 9.69%317K | 256.53%1.73M | -88.69%100K | -161.32%-1.22M | 214.08%2.56M |
| -Change in payables and accrued expense | 137.51%1.06M | -195.81%-3.04M | -71.43%826K | -132.00%-313K | -162.44%-738K | -49.89%-2.82M | 269.05%3.17M | 234.90%2.89M | 188.91%978K | 21.98%1.18M |
| -Change in other current assets | 66.80%-84K | -137.34%-90K | -70.41%337K | 210.00%121K | -187.54%-295K | 77.51%-253K | 104.24%241K | 108.61%1.14M | 37.50%-110K | 228.14%337K |
| -Change in other current liabilities | 164.29%37K | -269.32%-149K | -226.55%-143K | 167.24%39K | -447.06%-59K | -12.50%14K | -80.62%88K | 1,312.50%113K | -117.47%-58K | -70.18%17K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 74.95%-1.25M | 37.63%-8.72M | 23.11%-1.22M | 88.19%-676K | -505.12%-1.82M | 29.71%-5.01M | 26.26%-13.98M | 75.25%-1.58M | -19.93%-5.72M | 109.31%449K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -148.72%-19K | 80.00%-315K | 46.00%-162K | 60.22%-144K | 94.74%-48K | 39K | 88.71%-1.58M | -1,053.85%-300K | 97.39%-362K | -2,436.11%-913K |
| Net PPE purchase and sale | -148.72%-19K | 80.00%-315K | 46.00%-162K | 60.22%-144K | 94.74%-48K | --39K | -1,234.75%-1.58M | -1,053.85%-300K | -535.09%-362K | -2,436.11%-913K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -148.72%-19K | 80.00%-315K | 46.00%-162K | 60.22%-144K | 94.74%-48K | --39K | 88.71%-1.58M | -1,053.85%-300K | 97.39%-362K | -2,436.11%-913K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -78.96%1.06M | -45.94%8.98M | 2,530.77%1.26M | 105.63%209K | 12.23%2.47M | -72.30%5.03M | -43.05%16.61M | -100.81%-52K | -122.10%-3.71M | 4,250.94%2.2M |
| Net issuance payments of debt | -80.00%1M | 402.53%9.08M | --1.58M | --0 | 13.64%2.5M | 377.78%5M | 0.79%-3M | --0 | -190.67%-3.4M | --2.2M |
| Net common stock issuance | -45.37%59K | -12.30%335K | --0 | --227K | --0 | -75.12%108K | -94.07%382K | -110.26%-52K | --0 | --0 |
| Net preferred stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | -25.33%19.22M | --0 | -102.40%-314K | --0 |
| Net other financing activities | ---- | ---435K | ---312K | ---18K | ---31K | ---74K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -78.96%1.06M | -45.94%8.98M | 2,530.77%1.26M | 105.63%209K | 12.23%2.47M | -72.30%5.03M | -43.05%16.61M | -100.81%-52K | -122.10%-3.71M | 4,250.94%2.2M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.72%3.31M | 45.28%3.37M | -35.38%3.43M | -73.25%4.04M | -74.28%3.44M | 45.28%3.37M | -61.75%2.32M | 125.11%5.31M | 258.81%15.11M | 46.54%13.37M |
| Current changes in cash | -419.40%-214K | -105.52%-58K | 94.01%-116K | 93.76%-611K | -65.32%602K | -99.39%67K | 128.05%1.05M | -5,132.43%-1.94M | -429.05%-9.8M | 135.33%1.74M |
| End cash Position | -9.86%3.1M | -1.72%3.31M | -1.72%3.31M | -35.38%3.43M | -73.25%4.04M | -74.28%3.44M | 45.28%3.37M | 45.28%3.37M | 125.11%5.31M | 258.81%15.11M |
| Free cash flow | 74.57%-1.27M | 41.67%-9.07M | 26.75%-1.38M | 86.52%-820K | -302.37%-1.87M | 29.71%-5.01M | 18.51%-15.55M | 70.69%-1.88M | -26.01%-6.08M | 90.45%-464K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg